IRadimed Research Development from 2010 to 2026

46K Stock   83.50  3.00  3.47%   
IRadimed Research Development yearly trend continues to be comparatively stable with very little volatility. Research Development will likely drop to about 2.2 M in 2026. From the period from 2010 to 2026, IRadimed Research Development quarterly data regression had r-value of  0.84 and coefficient of variation of  34.12. View All Fundamentals
 
Research Development  
First Reported
2019-09-30
Previous Quarter
877.4 K
Current Value
674.4 K
Quarterly Volatility
160.2 K
 
Covid
 
Interest Hikes
Check IRadimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRadimed's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Net Interest Income of 2.6 M or Interest Income of 2.6 M, as well as many indicators such as . IRadimed financial statements analysis is a perfect complement when working with IRadimed Valuation or Volatility modules.
  
This module can also supplement various IRadimed Technical models . Check out the analysis of IRadimed Correlation against competitors.
The evolution of Research Development for IRadimed provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how IRadimed compares to historical norms and industry peers.

Latest IRadimed's Research Development Growth Pattern

Below is the plot of the Research Development of IRadimed over the last few years. It is IRadimed's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRadimed's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

IRadimed Research Development Regression Statistics

Arithmetic Mean1,841,895
Geometric Mean1,755,607
Coefficient Of Variation34.12
Mean Deviation507,530
Median1,517,112
Standard Deviation628,535
Sample Variance395.1B
Range1.9M
R-Value0.84
Mean Square Error124.1B
R-Squared0.71
Significance0.000025
Slope104,552
Total Sum of Squares6.3T

IRadimed Research Development History

20262.2 M
20253.3 M
20242.8 M
20232.9 M
20222.3 M
20211.9 M
20201.9 M

About IRadimed Financial Statements

IRadimed shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although IRadimed investors may analyze each financial statement separately, they are all interrelated. The changes in IRadimed's assets and liabilities, for example, are also reflected in the revenues and expenses on on IRadimed's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development3.3 M2.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IRadimed Stock Analysis

When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.